This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Menegatti M, Peyvandi F. Treatment of rare factor deficiencies other than hemophilia. Blood 2019; 133(5): 415–424. doi: 10.1182/blood-2018-06-820738.MenegattiMPeyvandiFTreatment of rare factor deficiencies other than hemophiliaBlood2019133541542410.1182/blood-2018-06-82073830559262Open DOISearch in Google Scholar
Pikija S, Gampenrieder SP, Millesi K, Pilz, G, Weis, S, Mutzenbach, JS. Factor VII deficiency in major artery occlusion stroke. Am J Hematol 2018; 93: 843–845. doi: 10.1002/ajh.25031.PikijaSGampenriederSPMillesiKPilzGWeisSMutzenbachJSFactor VII deficiency in major artery occlusion strokeAm J Hematol20189384384510.1002/ajh.2503129318701Open DOISearch in Google Scholar
Kim SH, Park YS, Kwon KH, Lee JH, Kim KC, Yoo MC. Surgery in patients with congenital factor VII deficiency: A single center experience. Korean J Hematol 2012; 47(4): 281–285. doi: 10.5045/kjh.2012.47.4.281.KimSHParkYSKwonKHLeeJHKimKCYooMCSurgery in patients with congenital factor VII deficiency: A single center experienceKorean J Hematol201247428128510.5045/kjh.2012.47.4.281353880023320007Open DOISearch in Google Scholar
Mahale R, Rathi P, Ginegiri C, Aggarwal R. Factor VII deficiency: A rare case report. Indian J Hematol Blood Transfus 2010; 26: 68–9. doi: 10.1007/s12288-010-0023-5.MahaleRRathiPGinegiriCAggarwalRFactor VII deficiency: A rare case reportIndian J Hematol Blood Transfus20102668910.1007/s12288-010-0023-5300206821629640Open DOISearch in Google Scholar
ELShama HA, ELokda SA. Effect of activated recombinant factor VII versus tranexamic acid infusion on bleeding during spine surgery, randomized, controlled, double blinded trial. Egyptian Journal of Anaesthesia 2015; 31(2): 149–153. doi: 10.1016/j.egja.2014.12.009.ELShamaHAELokdaSAEffect of activated recombinant factor VII versus tranexamic acid infusion on bleeding during spine surgery, randomized, controlled, double blinded trialEgyptian Journal of Anaesthesia201531214915310.1016/j.egja.2014.12.009Open DOISearch in Google Scholar
Ingerslev J, Knudsen L, Hvid I, Tange MR, Fredberg U, Sneppen O. Use of recombinant factor VIIa in surgery in factor-VII-deficient patients. Haemophilia 1997; 3(3): 215–218. doi: 10.1046/j.1365-2516.1997.00105.x.IngerslevJKnudsenLHvidITangeMRFredbergUSneppenOUse of recombinant factor VIIa in surgery in factor-VII-deficient patientsHaemophilia19973321521810.1046/j.1365-2516.1997.00105.x27214810Open DOISearch in Google Scholar
Tokgoz H, Caliskan U, Lavigne-Lissalde G, Giansily-Blaizot M. Successful prophylactic use of recombinant activated factor VII (rFVIIa) in a patient with congenital FVII deficiency and inhibitors to FVII. Haemophilia 2012; 18(1): e25–7. doi: 10.1111/j.1365-2516.2011.02666.x.TokgozHCaliskanULavigne-LissaldeGGiansily-BlaizotMSuccessful prophylactic use of recombinant activated factor VII (rFVIIa) in a patient with congenital FVII deficiency and inhibitors to FVIIHaemophilia2012181e25710.1111/j.1365-2516.2011.02666.x21973016Open DOISearch in Google Scholar
Şenol BK, Zülfikar B. Clinical problems and surgical interventions in inherited factor VII deficiency. Turk Pediatri Ars 2020; 55(2): 184–190. doi: 10.14744/TurkPediatriArs.2020.79069.ŞenolBKZülfikarBClinical problems and surgical interventions in inherited factor VII deficiencyTurk Pediatri Ars202055218419010.14744/TurkPediatriArs.2020.79069734412732684764Open DOISearch in Google Scholar
Nicolaisen EM. Antigenicity of activated recombinant factor VII followed through nine years of clinical experience. Blood Coagul Fibrinolysis 1998; 9 Suppl 1: S119–23.NicolaisenEMAntigenicity of activated recombinant factor VII followed through nine years of clinical experienceBlood Coagul Fibrinolysis19989Suppl 1S11923Search in Google Scholar
Shams M, Dorgalaleh A, Safarian N, et al. Inhibitor development in patients with congenital factor VII deficiency, a study on 50 Iranian patients. Blood Coagul Fibrinolysis 2019; 30(1): 24–28. doi: 10.1097/MBC.0000000000000791.ShamsMDorgalalehASafarianNInhibitor development in patients with congenital factor VII deficiency, a study on 50 Iranian patientsBlood Coagul Fibrinolysis2019301242810.1097/MBC.000000000000079130585836Open DOISearch in Google Scholar
Levitt MJ, Topilow AA, Lerner W, et al. A case of FVII inhibitor. Blood 2010; 116(21): 3655. doi: 10.1182/blood.V116.21.3655.3655.LevittMJTopilowAALernerWA case of FVII inhibitorBlood201011621365510.1182/blood.V116.21.3655.3655Open DOISearch in Google Scholar
Brewer A, Correa ME; World Federation of Hemophilia Dental Committee. Guidelines for dental treatment of patients with inherited bleeding disorders. World Federation of Hemophilia, Treatment of Hemophilia, 2006. Available from https://elearning.wfh.org/resource/guidelines-for-dental-treatment-of-patients-with-inherited-bleeding-disorders/ (accessed 23 April 2021).BrewerACorreaMEWorld Federation of Hemophilia Dental CommitteeGuidelines for dental treatment of patients with inherited bleeding disordersWorld Federation of Hemophilia, Treatment of Hemophilia2006Available from https://elearning.wfh.org/resource/guidelines-for-dental-treatment-of-patients-with-inherited-bleeding-disorders/ (accessed 23 April 2021).Search in Google Scholar
Weinstock RJ, Onyejiuwa A, Shnayder G, Clarkson EI. Use of recombinant factor VII for tooth extractions in a patient with severe congenital factor VII deficiency: a case report. J Am Dent Assoc 2015; 146(4): 271–5. doi: 10.1016/j.adaj.2014.12.022.WeinstockRJOnyejiuwaAShnayderGClarksonEIUse of recombinant factor VII for tooth extractions in a patient with severe congenital factor VII deficiency: a case reportJ Am Dent Assoc20151464271510.1016/j.adaj.2014.12.02225819659Open DOISearch in Google Scholar
Peisker A, Raschke GF, Schultze-Mosgau S. Management of dental extraction in patients with Haemophilia A and B: a report of 58 extractions. Med Oral Patol Oral Cir Bucal 2014; 19(1): e55–e60. doi: 10.4317/medoral.19191.PeiskerARaschkeGFSchultze-MosgauSManagement of dental extraction in patients with Haemophilia A and B: a report of 58 extractionsMed Oral Patol Oral Cir Bucal2014191e55e6010.4317/medoral.19191390943324121912Open DOISearch in Google Scholar
Kazancıoğlu HO, Çakıir O, Gülsüm A, Zülfikar B. The effectiveness of a new hemostatic agent (Ankaferd Blood Stopper) for the control of bleeding following tooth extraction in hemophilia: A controlled clinical trial. Turk J Hematol 2013; 30: 19–24. doi: 10.4274/tjh.2012.0036.KazancıoğluHOÇakıirOGülsümAZülfikarBThe effectiveness of a new hemostatic agent (Ankaferd Blood Stopper) for the control of bleeding following tooth extraction in hemophilia: A controlled clinical trialTurk J Hematol201330192410.4274/tjh.2012.0036378166724385748Open DOISearch in Google Scholar